1-(Bromomethyl)-2-(tert-butyl)benzene

Catalog No.: 
ACGCCR823
CAS No.: 
1005751-00-7
Molecular Formula: 
C11H15Br
Molecular Weight: 
227.15
1-(Bromomethyl)-2-(tert-butyl)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$359.00InquiryInquiry
100mg95%$527.00InquiryInquiry
250mg95%$743.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Bromomethyl)-2-(tert-butyl)benzene
IUPAC Name1-(bromomethyl)-2-(tert-butyl)benzene
MDL No.MFCD15527516
Molecular FormulaC11H15Br
Molecular Weight227.15
SMILESCC(C1=CC=CC=C1CBr)(C)C
InChI KeyHQMURGXQJSHZSO-UHFFFAOYSA-N
Synonym1-(Bromomethyl)-2-(tert-butyl)benzene;2-tert-Butylbenzyl bromide;Benzene, 1-(bromomethyl)-2-(1,1-dimethylethyl)-;1-(Bromomethyl)-2-(2-methyl-2-propanyl)benzene
CAS No.1005751-00-7

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACGCCR823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGCCR823 route product structure diagram
    ACGCCR8231005751-00-7
Inquiry

2. ACGCCR823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGCCR823 route product structure diagram
    ACGCCR8231005751-00-7
Inquiry

3. ACGCCR823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGCCR823 route product structure diagram
    ACGCCR8231005751-00-7
Inquiry

Comments (0)